Sentences with phrase «week placebo treatment»

After one six - week placebo treatment, one six - week period of taking 700 mg Green Coffee Bean Extract, one six - week period of taking 1050 mg Green Coffee Bean Extract and two two - week wash - out periods the subjects lost 8.1 kg in bodyweight.

Not exact matches

Treatment with zoledronic acid was associated with an eight percent increase in lumbar spine bone marrow density at 12 weeks relative to the placebo arm, with an 11 percent increase at 24 and 48 weeks.

Treatment with zoledronic acid was associated with a 73 percent and a 65 percent reduction in bone loss relative to placebo at 12 weeks and 24 weeks respectively, an effect that lasted throughout the 48 weeks of the study.

Hep C patients being treated for opioid addiction achieved high rates of sustained virologic response after 12 weeks of therapy with elbasvir - grazoprevir compared to those taking placebo for 12 weeks before beginning the drug treatment.

In the four weeks after the first treatments, people had about 15 percent fewer days of headache compared with a placebo or dummy injection.

Researchers here recruited thirty patients with primary insomnia, who underwent neurofeedback treatment and placebo - feedback treatment over several weeks.

The order of trainings, that is, real or placebo neurofeedback treatment was counterbalanced across subjects and the twelve sessions were completed within 4 weeks.

After four weeks of hospital treatment, the subjects taking the drug reported fewer spontaneous and stress - induced alcohol cravings than patients given a placebo did.

For 24 weeks, 1,583 participants in the aptly named GAIT (Glucosamine / chondroitin Arthritis Intervention Trial) were given one of the following treatments: glucosamine, chondroitin sulfate, both in combination, a placebo, or the COX - 2 inhibitor Celebrex (celecoxib) as a control.

For those in the treatment group, the number of seizures per month was cut roughly in half, on average, compared to a negligible decline in the placebo group, researchers reported this week in The New England Journal of Medicine.

Six weeks of treatment by the highest dose of dronabinol (10 milligrams) was associated with a lower frequency of apneas or hypopneas (overly shallow breathing) during sleep, decreased subjective sleepiness and greater overall treatment satisfaction compared to the placebo group.

The patients used each treatment (candesartan, propranolol or placebo) for 12 weeks, and also underwent four weeks before start and between the treatment periods without any medication at all.

Furthermore, in mothers who gave birth in winter, vitamin D concentrations fell from 14 to 34 weeks gestation in the placebo group, but rose in the treatment group.

According to the trial's crossover design, patients with refractory chronic cough of at least eight weeks» duration were randomly assigned initially to either AF - 219 or placebo treatment twice daily for two weeks, followed by a washout period, and further followed by crossover to the alternative treatment arm (AF - 219 or placebo) for an additional two weeks.

Among cigarette smokers not willing or able to quit smoking in the next month but willing to reduce with the goal of quitting in the next 3 months, use of the nicotine addiction medication varenicline for 24 weeks compared with placebo produced greater reductions in smoking prior to quitting and increased smoking cessation rates at the end of treatment and at 1 year, according to a study in the February 17 issue of JAMA.

A few weeks later the rats that received the drug showed improvements in walking and urinating while the placebo treatments had no effect.

The researchers found that the addition of vitamin D3 to ciclesonide did not significantly reduce the rate of first treatment failure (a composite outcome of decline in lung function and increases in use of beta - agonists, systemic steroids, and health care utilization) compared with placebo; 28 percent and 29 percent of participants in each group, respectively, experienced at least 1 treatment failure during 28 weeks.

After 24 weeks of treatment, 43 to 60 percent of patients saw an improvement of about nine to 14 percent over placebo, which translated to an additional 0.5 to one satisfying sexual experience per month.

Study participants (n = 146; 101 males, 45 females) were enrolled in a 16 - week randomized clinical trial comparing naltrexone with placebo treatment.

Mario Castro, M.D., M.P.H., of the Washington University School of Medicine, St. Louis, and colleagues randomly assigned adults with asthma and low vitamin D levels to vitamin D3 (100,000 IU once, then 4,000 IU / daily for 28 weeks; n = 201) or placebo (n = 207), which was added to treatment with the inhaled corticosteroid ciclesonide.

They then received two weeks of placebo pill treatment — but during one of those weeks, each was told they were taking a substance that is believed to activate internal mechanisms and may have antidepressant properties.

By the end of treatment, the odds of experiencing a heavy drinking day in the placebo group was five times more than that of the topiramate group; and the number of patients who experienced no heavy drinking days on the last four weeks of treatment in the topirmate group was more than double that of the placebo group.

The randomized double - blind trial included a total of 138 heavy drinkers, approximately half of whom received 12 weeks of treatment with topiramate at a maximal dosage of 200 mg / day and half of whom received a placebo.

As early as 4 weeks into treatment, 21 % in the guselkumab group had a significant treatment effect on ACR20 response, compared to zero in the placebo group (p < 0.001).

The median time of treatment was 7 weeks for napabucasin and 6.6 weeks for placebo.

The children received omalizumab or a placebo for eight weeks before starting immunotherapy and for eight weeks during combination treatment with immunotherapy for two to five trigger foods.

In a placebo controlled double - blind study of frail elderly patients, treatment with NAC doubled the increase in knee extensor strength during a 6 - week program of physical exercise and slowed the subsequent decline during a 6 - week follow - up period.

The men were treated with a Maca extract of 2400 mg or a placebo, and the effect of the Maca treatment was tested using the International Index of Erectile Function (IIEF - 5) before and after 12 weeks of treatment.

A preliminary clinical study showed that infertile men who took coenzyme CoQ10 at 300 mg daily had significantly improved sperm density and motility after 26 weeks of treatment compared with placebo.

Women with PCOS were randomly selected to take berberine, metformin, or placebo for 12 weeks prior to IVF treatment.

This was a 12 week double blind placebo controlled, randomized, parallel trial to study the effect of Maca treatment on subjective report of sexual desire.

The study involved 62 adults with a high body mass index, each of whom was assigned to 12 weeks of treatment with Lactobacillus gasseri BNR17 or a placebo.

They fed 100 mg of berberine or a placebo to rats for several weeks and noted that «berberine treatment not only augments GLP2 secretion and improves diabetes, but is also effective in repairing the damaged intestinal mucosa, restoring intestinal permeability and improving endotoxemia».

In a small study published in the Journal of the American College of Nutrition in 2001, for instance, 46 people with high cholesterol were placed on a low - fat diet and assigned to 12 weeks of treatment with either a placebo or enteric - coated garlic powder tablets designed to deliver 9.6 mg of allicin.

, Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: A six - week placebo - controlled, double - blind, multicentre trial, 2003

The effects of a 4 - week oral treatment with alpha - lipoic acid were evaluated in a placebo - controlled, multicenter pilot study to determine see whether oral treatment also improves insulin sensitivity.

After 2 to 6 weeks of treatment with 20 g / d of fructo - oligosaccharides or placebo, symptoms of irritable bowel syndrome improved more in the placebo group than in the fructooligosaccharide group; however, there was no difference between the groups after con - tinuous treatment for 12 weeks.

The study, held in Ontario, Canada, divided 202 patients in treatment and placebo groups and treated the over a period of twelve weeks.

In a trial of dogs with allergic dermatitis, treatment success, as defined by owner - assessed decrease in pruritus, occurred in 67 percent of dogs treated with APOQUEL vs. 29 percent of dogs treated with placebo after one week of treatment.

Outpatients (N = 421) in primary care or psychiatry settings meeting DSM - IV criteria for GAD were randomly assigned to 6 weeks of double - blind treatment with pregabalin 400 or 600 mg / day, venlafaxine 75 mg / day, or placebo.

Hollander et al used a double blind, placebo controlled design to examine the efficacy of a 10 week treatment of lithium on the clinical and cognitive features of gambling in pathological gamblers with bipolar spectrum disorder.